An online database, required by the recent health care law, provides a detailed look at the payments health care professionals receive from drug and medical device companies and is part of a broader push for transparency. Proponents say such disclosures are an important tool to help limit drug and device makers’ influence on doctors, but the website is being questioned by the industry, which says that technical problems and data inaccuracies limit its value. Reisa Sperling, professor of neurology at Brigham and Women’s Hospital, is mentioned.
